Jobstacky
Loading...
Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE101, targets the cytokine APRIL, and is currently being evaluated for the treatment of immunoglobulin A nephropathy. Jade’s pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, as well as JADE301, an anti-IFN-β monoclonal antibody. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount. For more information, visit JadeBiosciences.com and follow the Company on LinkedIn .
No applications have been reported here yet. Be the first to track one.
Explore real hiring signals for JADEBIOSCIENCES, including current job status trends, application volumes, and community interview discussions from Jobstacky users. This page helps you see which roles are active, which teams are paused, and where referral momentum is building.
No application data yet.
United States
3 · 60%
Canada
2 · 40%
What people are sharing about applying and interviewing at JADEBIOSCIENCES.
Open full pageLoading discussions